Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
R Core Team
doi: 10.1016/S2213-8587(19)30249-9 67 FudimMWhiteJPagidipatiNJLokhnyginaYWainsteinJMurinJet al
Culturing nave CD4+ T cells under conditions that mimicked mucosal environments, including signaling through MAdCAM-1 in the presence of retinoic acid and TGF-, primed them to adopt a TRM phenotype
By October 2024, the blockbuster drug tirzepatide had transformed Lilly into the most valuable drug company in the world
Verhoef et al, 1997a
US$ 20.79
:max_bytes(150000):strip_icc()/3123217-56b7105a5f9b5829f83631a7.JPG)
US$ 22.35
US$ 20.25
US$ 22.49
US$ 26.11
US$ 25.24
